Immune classification of colorectal cancer patients: impressive but how complete? (Q38071673)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 06 January 2013

Language	Label	Description	Also known as
English	Immune classification of colorectal cancer patients: impressive but how complete?	scientific article published on 06 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

Immune classification of colorectal cancer patients: impressive but how complete? (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Constantin N Baxevanis

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Michael Papamichail

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sonia A Perez

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

language of work or name

0 references

publication date

6 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

517-526

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Tumor microenvironment and lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Role of immature myeloid cells in mechanisms of immune evasion in cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Disarming suppressor cells to improve immunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Th17 cells in cancer: help or hindrance?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

T(H)17 cells in tumour immunity and immunotherapy.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Endogenous IL-17 contributes to reduced tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Inflammation and prognosis in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Lymph node evaluation and survival after curative resection of colon cancer: systematic review

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Systematic review of microsatellite instability and colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Natural killer cells in human cancer: from biological functions to clinical applications

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Th17 cytokines and mucosal immunity

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

IL-17-producing human peripheral regulatory T cells retain suppressive function

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-specific Th17-polarized cells eradicate large established melanoma

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Generation and Differentiation of IL-17–Producing CD4+ T Cells in Malignant Pleural Effusion

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Plasticity of CD4(+) FoxP3(+) T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Immune responses to malignancies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

FOXP3 and survival in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Combining immunotherapy and targeted therapies in cancer treatment

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Immunological aspects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

The immune contexture in human tumours: impact on clinical outcome

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.751971

21 January 2018

Identifiers

10.1517/14712598.2013.751971

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38071673&oldid=2132928755"